Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of poor-risk myelodysplastic syndromes and acute myeloid leukaemia.
| Autor: | Parker, J. E., Pagliuca, A., Mijovic, A., Cullis, J. O., Czepulkowski, B., Rassam, S. M. B., Samaratunga, I. R., Grace, R., Gover, P. A., Mufti, G. J. |
|---|---|
| Zdroj: | British Journal of Haematology; Dec1997, Vol. 99 Issue 4, p939-944, 6p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|
Plný text